Literature DB >> 12764676

Hypertriglyceridemia associated with amino acid variation Asn985Tyr of the RP1 gene.

Yuko Fujita1,2, Yoichi Ezura1, Mitsuru Emi3, Shuji Ono1, Daisuke Takada1,2, Kaneo Takahashi4, Kouhei Uemura4, Yasuhiko Iino2, Yasuo Katayama2, Hideaki Bujo5, Yasushi Saito6.   

Abstract

Factors predisposing to the phenotypic features of hypertriglyceridemia have not been clearly defined. Here we report an association between a missense coding region polymorphism Asn985Tyr in the retinitis pigmentosa 1 gene ( RP1) and plasma triglyceride (TG) levels in 332 adult individuals from an east-central area of Japan. Age and gender-adjusted levels of LDL-cholesterol, TG, and HDL-cholesterol were analyzed. When we separate the subjects into two genotypic groups regarding this amino acid variation, those who lack the 985-Asn allele (asparagine at residue 985) had significantly higher plasma TG levels than the others who had at least one 985-Asn allele (mean: 175.8 mg/dl vs 123.3 mg/dl; P=0.0006, Mann-Whitney test). Similarly, the former subjects had significantly lower HDL-cholesterol levels than the latter (mean: 48.0 mg/dl vs 53.8 mg/dl; P=0.038). Of the 280 individuals without a 985-Asn allele, approximately half of the individuals presented with hypertriglyceridemia, whereas only a quarter were hypertriglyceridemic among 52 individuals with the 985-Asn allele ( P=0.04). Although this SNP marker may itself be in linkage disequilibrium with other unexamined functional variants within this locus, our data suggest that genetic variation at the RP1 locus is one of the likely candidate determinants for plasma triglyceride and HDL-cholesterol metabolisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764676     DOI: 10.1007/s10038-003-0029-z

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  18 in total

1.  A high-throughput SNP typing system for genome-wide association studies.

Authors:  Y Ohnishi; T Tanaka; K Ozaki; R Yamada; H Suzuki; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

Review 2.  Development of genetic hypotheses in essential hypertension.

Authors:  J M Lalouel; A Rohrwasser
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

3.  A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.

Authors:  N Ota; T Nakajima; I Nakazawa; T Suzuki; T Hosoi; H Orimo; S Inoue; Y Shirai; M Emi
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

Review 4.  Significance of hypertriglyceridemia in the occurrence of ischemic heart disease.

Authors:  Y Matsuzawa
Journal:  J Atheroscler Thromb       Date:  1995       Impact factor: 4.928

5.  Mutations in a novel retina-specific gene cause autosomal dominant retinitis pigmentosa.

Authors:  L S Sullivan; J R Heckenlively; S J Bowne; J Zuo; W A Hide; A Gal; M Denton; C F Inglehearn; S H Blanton; S P Daiger
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

6.  Mutations in a gene encoding a new oxygen-regulated photoreceptor protein cause dominant retinitis pigmentosa.

Authors:  E A Pierce; T Quinn; T Meehan; T L McGee; E L Berson; T P Dryja
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

7.  Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms, and haplotype analysis.

Authors:  I Nakazawa; T Nakajima; H Harada; T Ishigami; S Umemura; M Emi
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

8.  Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects.

Authors:  M Norioka; M Suzuki; K Ryomoto; M Ikebuchi; Y Harano
Journal:  J Atheroscler Thromb       Date:  2000       Impact factor: 4.928

9.  Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis.

Authors:  Jun Ishii; Makoto Nagano; Takeshi Kujiraoka; Mitsuaki Ishihara; Tohru Egashira; Daisuke Takada; Masahiro Tsuji; Hiroaki Hattori; Mitsuru Emi
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

Review 10.  Lipoproteins and cardiovascular risk-from genetics to CHD prevention.

Authors:  P Cullen; H Funke; H Schulte; G Assmann
Journal:  J Atheroscler Thromb       Date:  1997       Impact factor: 4.928

View more
  5 in total

1.  Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia.

Authors:  Yuko Fujita; Yoichi Ezura; Hideaki Bujo; Toshiaki Nakajima; Kaneo Takahashi; Kouhei Kamimura; Yasuhiko Iino; Yasuo Katayama; Yasushi Saito; Mitsuru Emi
Journal:  J Hum Genet       Date:  2005-04-14       Impact factor: 3.172

2.  Hypercholesterolemia associated with splice-junction variation of inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) gene.

Authors:  Yuko Fujita; Yoichi Ezura; Mitsuru Emi; Keiko Sato; Daisuke Takada; Yasuhiko Iino; Yasuo Katayama; Kaneo Takahashi; Kouhei Kamimura; Hideaki Bujo; Yasushi Saito
Journal:  J Hum Genet       Date:  2003-12-06       Impact factor: 3.172

3.  Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients.

Authors:  Mitsuaki Ishihara; Tadao Iwasaki; Makoto Nagano; Jun Ishii; Mayumi Takano; Takeshi Kujiraoka; Masahiro Tsuji; Hiroaki Hattori; Mitsuru Emi
Journal:  J Hum Genet       Date:  2004-05-18       Impact factor: 3.172

4.  The effect of a novel intergenic polymorphism (rs11774572) on HDL-cholesterol concentrations depends on TaqIB polymorphism in the cholesterol ester transfer protein gene.

Authors:  M Junyent; Y-C Lee; C E Smith; D K Arnett; M Y Tsai; E K Kabagambe; R J Straka; M Province; P An; C-Q Lai; L D Parnell; J Shen; I Borecki; J M Ordovas
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-11       Impact factor: 4.222

5.  A novel mutation in C5L2 gene was associated with hyperlipidemia and retinitis pigmentosa in a Chinese family.

Authors:  Ling-Hui Qu; Xin Jin; Liang-Mao Li; Shi-Ying Li; Han-Ping Xie
Journal:  Lipids Health Dis       Date:  2014-05-06       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.